Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

276
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
276
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

277
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
277
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

212
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
212
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

376
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
376
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

646
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
646
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

172
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Main Recommendations for Developing Education and Awareness Strategies for Rare Diseases: Scoping Review.

JMIR medical education·2026
Same author

From Spreadsheets to FHIR and Research Databases: Digitizing Medication Data in Elderly Care Within the RM4Health Project.

Studies in health technology and informatics·2026
Same author

ReprodutHIVa: development and validation of an app for self-care for women living with HIV/AIDS.

Revista latino-americana de enfermagem·2026
Same author

Diagnostic accuracy and safety of Diaskintest<sup>®</sup> compared with the tuberculin skin test for detecting tuberculosis infection in BCG-vaccinated Brazilian adults.

Frontiers in medicine·2026
Same author

Nationwide epidemiological study of tuberculosis and other respiratory pathogens among children and adolescents in Brazil: TBPed Brazil study protocol.

PloS one·2026
Same author

Evaluation of T-NGS, Xpert Ultra, and Line Probe Assay on Clinical Samples for the Diagnosis of Drug-Resistant Pulmonary Tuberculosis in Rio de Janeiro.

Revista da Sociedade Brasileira de Medicina Tropical·2025

Related Experiment Video

Updated: Jul 25, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.1K

A Computational Infrastructure for Analyzing Tuberculosis Research Data in Brazil.

Mariana Mozini1, Filipe Bernardi2, Ana Clara Mioto2

  • 1Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Studies in Health Technology and Informatics
|June 30, 2023
PubMed
Summary
This summary is machine-generated.

This study outlines a tuberculosis (TB) research pipeline in Brazil to improve data quality. High-quality data is crucial for effective public health policies against this deadly infectious disease.

Keywords:
Data ScienceResearch dataTuberculosis

More Related Videos

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

234
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

1.7K

Related Experiment Videos

Last Updated: Jul 25, 2025

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA
10:41

A Tuberculosis Molecular Bacterial Load Assay TB-MBLA

Published on: April 30, 2020

14.1K
Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples
06:07

Matrix-based DNA Extraction for Targeted Next-Generation Sequencing on Decontaminated Sputum Samples

Published on: June 6, 2025

234
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

1.7K

Area of Science:

  • Public Health
  • Infectious Diseases
  • Health Informatics

Background:

  • Tuberculosis (TB) remains a leading cause of death globally, with 6.4 million new cases in 2021.
  • Drug-resistant TB strains emerge due to factors like poor hygiene and substandard medications.
  • The World Health Organization's End TB Strategy requires robust health data for effective policy.

Purpose of the Study:

  • To describe a pipeline for tuberculosis research in Brazil.
  • To address challenges in generating high-quality health data for TB control.
  • To support the creation of effective public health policies.

Main Methods:

  • Development of a data generation pipeline tailored for TB research.
  • Integration of technological advancements like Big Data and the Internet of Things.
  • Focus on overcoming obstacles in health information generation.

Main Results:

  • A structured pipeline for TB research data acquisition in Brazil has been described.
  • The pipeline aims to enhance the reliability and quality of health data.
  • Potential to improve public health policy formulation for TB control.

Conclusions:

  • High-quality health data is essential for combating tuberculosis effectively.
  • The proposed pipeline offers a framework to improve data generation for TB research in Brazil.
  • Addressing data challenges is critical for achieving the goals of the End TB Strategy.